INSERM U609/Inserm-EPFL Joint Laboratory,Global Health Institute, Lausanne, Switzerland.
Cell Microbiol. 2011 Jun;13(6):836-45. doi: 10.1111/j.1462-5822.2011.01582.x. Epub 2011 Mar 4.
Merozoites of malaria parasites invade red blood cells (RBCs), where they multiply by schizogony, undergoing development through ring, trophozoite and schizont stages that are responsible for malaria pathogenesis. Here, we report that a protein kinase-mediated signalling pathway involving host RBC PAK1 and MEK1, which do not have orthologues in the Plasmodium kinome, is selectively stimulated in Plasmodium falciparum-infected (versus uninfected) RBCs, as determined by the use of phospho-specific antibodies directed against the activated forms of these enzymes. Pharmacological interference with host MEK and PAK function using highly specific allosteric inhibitors in their known cellular IC50 ranges results in parasite death. Furthermore, MEK inhibitors have parasiticidal effects in vitro on hepatocyte and erythrocyte stages of the rodent malaria parasite Plasmodium berghei, indicating conservation of this subversive strategy in malaria parasites. These findings have profound implications for the development of novel strategies for antimalarial chemotherapy.
疟原虫的裂殖子侵入红细胞(RBC),在那里通过裂体生殖进行繁殖,经历环、滋养体和裂殖体阶段的发育,这些阶段是疟疾发病机制的原因。在这里,我们报告了一种蛋白激酶介导的信号通路,涉及宿主 RBC 的 PAK1 和 MEK1,它们在疟原虫激酶组中没有同源物,在疟原虫感染(与未感染)的 RBC 中被选择性地刺激,这是通过使用针对这些酶的激活形式的磷酸特异性抗体来确定的。在其已知的细胞 IC50 范围内使用高度特异性的变构抑制剂对宿主 MEK 和 PAK 功能进行药理学干扰,导致寄生虫死亡。此外,MEK 抑制剂在体外对啮齿动物疟原虫寄生虫肝细胞和红细胞阶段具有杀寄生虫作用,表明这种颠覆性策略在疟原虫中是保守的。这些发现对开发新的抗疟化疗策略具有深远的意义。